Skip to main content
Top
Published in: Annals of Nuclear Medicine 3/2013

01-04-2013 | Case report

SPG3A-linked hereditary spastic paraplegia associated with cerebral glucose hypometabolism

Authors: Tatsuhiro Terada, Satoshi Kono, Yasuomi Ouchi, Kenichi Yoshida, Yasushi Hamaya, Shigeru Kanaoka, Hiroaki Miyajima

Published in: Annals of Nuclear Medicine | Issue 3/2013

Login to get access

Abstract

SPG3A-linked hereditary spastic paraplegia (HSP) is a rare autosomal dominant motor disorder caused by a mutation in the SPG3A gene, and is characterized by progressive motor weakness and spasticity in the lower limbs, without any other neurological abnormalities. SPG3A-linked HSP caused by a R239C mutation has been reported to present a pure phenotype confined to impairment of the corticospinal tract. However, there is still a debate about the etiology of this motor deficit with regard to whether it is peripheral or central. We herein report two patients who were heterozygous for a R239C mutation in the SPG3A gene. Two middle-aged Japanese sisters had been suffering from a pure phenotype of HSP since their childhood. Both patients had a significant decrease in glucose metabolism in the frontal cortex medially and dorsolaterally in a [18F]-fluorodeoxyglucose (FDG) positron emission photography (PET) study and low scores on the Frontal Assessment Battery. A real-time PCR analysis in normal subjects showed the frontal cortex to be the major location where SPG3A mRNA is expressed. The present finding that the frontal glucose hypometabolism was associated with frontal cognitive impairment indicates that widespread neuropathology associated with mutations in the SPG3A gene may be present more centrally than previously assumed.
Literature
2.
go back to reference Salinas S, Proukakis C, Crosby A, Warner TT. Hereditary spastic paraplegia: clinical features and pathogenetic mechanisms. Lancet Neurol. 2008;7:1127–38.PubMedCrossRef Salinas S, Proukakis C, Crosby A, Warner TT. Hereditary spastic paraplegia: clinical features and pathogenetic mechanisms. Lancet Neurol. 2008;7:1127–38.PubMedCrossRef
3.
go back to reference Zhao X, Alvarado D, Rainier S, Lemons R, Hedera P, Weber CH, et al. Mutations in a newly identified GTPase gene cause autosomal dominant hereditary spastic paraplegia. Nat Genet. 2001;29:326–31.PubMedCrossRef Zhao X, Alvarado D, Rainier S, Lemons R, Hedera P, Weber CH, et al. Mutations in a newly identified GTPase gene cause autosomal dominant hereditary spastic paraplegia. Nat Genet. 2001;29:326–31.PubMedCrossRef
4.
go back to reference Depienne C, Stevanin G, Brice A, Durr A. Hereditary spastic paraplegias: an update. Curr Opin Neurol. 2007;20:674–80.PubMedCrossRef Depienne C, Stevanin G, Brice A, Durr A. Hereditary spastic paraplegias: an update. Curr Opin Neurol. 2007;20:674–80.PubMedCrossRef
5.
go back to reference Hedera P, Fenichel GM, Blair M, Haines JL. Novel mutation in the SPG3A gene in an African American family with an early onset of hereditary spastic paraplegia. Arch Neurol. 2004;61:1600–3.PubMedCrossRef Hedera P, Fenichel GM, Blair M, Haines JL. Novel mutation in the SPG3A gene in an African American family with an early onset of hereditary spastic paraplegia. Arch Neurol. 2004;61:1600–3.PubMedCrossRef
6.
go back to reference Abel A, Fonknechten N, Hofer A, Durr A, Cruaud C, Voit T, et al. Early onset autosomal dominant spastic paraplegia caused by novel mutations in SPG3A. Neurogenetics. 2004;5:239–43.PubMedCrossRef Abel A, Fonknechten N, Hofer A, Durr A, Cruaud C, Voit T, et al. Early onset autosomal dominant spastic paraplegia caused by novel mutations in SPG3A. Neurogenetics. 2004;5:239–43.PubMedCrossRef
7.
go back to reference Wilkinson PA, Hart PE, Patel H, Warner TT, Crosby AH. SPG3A mutation screening in English families with early onset autosomal dominant hereditary spastic paraplegia. J Neurol Sci. 2003;216:43–5.PubMedCrossRef Wilkinson PA, Hart PE, Patel H, Warner TT, Crosby AH. SPG3A mutation screening in English families with early onset autosomal dominant hereditary spastic paraplegia. J Neurol Sci. 2003;216:43–5.PubMedCrossRef
8.
go back to reference Zhu PP, Patterson A, Lavoie B, Stadler J, Shoeb M, Patel R, et al. Cellular localization, oligomerization, and membrane association of the hereditary spastic paraplegia 3A (SPG3A) protein atlastin. J Biol Chem. 2003;278:49063–71.PubMedCrossRef Zhu PP, Patterson A, Lavoie B, Stadler J, Shoeb M, Patel R, et al. Cellular localization, oligomerization, and membrane association of the hereditary spastic paraplegia 3A (SPG3A) protein atlastin. J Biol Chem. 2003;278:49063–71.PubMedCrossRef
9.
go back to reference Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE. A diagnostic approach in Alzheimer’s disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med. 1995;36:1238–48.PubMed Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE. A diagnostic approach in Alzheimer’s disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med. 1995;36:1238–48.PubMed
10.
go back to reference Scarano V, Mancini P, Criscuolo C, De Michele G, Rinaldi C, Tucci T, et al. The R495W mutation in SPG3A causes spastic paraplegia associated with axonal neuropathy. J Neurol. 2005;252:901–3.PubMedCrossRef Scarano V, Mancini P, Criscuolo C, De Michele G, Rinaldi C, Tucci T, et al. The R495W mutation in SPG3A causes spastic paraplegia associated with axonal neuropathy. J Neurol. 2005;252:901–3.PubMedCrossRef
11.
go back to reference Ivanova N, Claeys KG, Deconinck T, Litvinenko I, Jordanova A, Auer-Grumbach M, et al. Hereditary spastic paraplegia 3A associated with axonal neuropathy. Arch Neurol. 2007;64:706–13.PubMedCrossRef Ivanova N, Claeys KG, Deconinck T, Litvinenko I, Jordanova A, Auer-Grumbach M, et al. Hereditary spastic paraplegia 3A associated with axonal neuropathy. Arch Neurol. 2007;64:706–13.PubMedCrossRef
12.
go back to reference Fusco C, Frattini D, Farnetti E, Nicoli D, Casali B, Fiorentino F, et al. Hereditary spastic paraplegia and axonal motor neuropathy caused by a novel SPG3A de novo mutation. Brain Dev. 2010;32:592–4.PubMedCrossRef Fusco C, Frattini D, Farnetti E, Nicoli D, Casali B, Fiorentino F, et al. Hereditary spastic paraplegia and axonal motor neuropathy caused by a novel SPG3A de novo mutation. Brain Dev. 2010;32:592–4.PubMedCrossRef
13.
go back to reference Namekawa M, Muriel MP, Janer A, Latouche M, Dauphin A, Debeir T, et al. Mutations in the SPG3A gene encoding the GTPase atlastin interfere with vesicle trafficking in the ER/Golgi interface and Golgi morphogenesis. Mol Cell Neurosci. 2007;35:1–13.PubMedCrossRef Namekawa M, Muriel MP, Janer A, Latouche M, Dauphin A, Debeir T, et al. Mutations in the SPG3A gene encoding the GTPase atlastin interfere with vesicle trafficking in the ER/Golgi interface and Golgi morphogenesis. Mol Cell Neurosci. 2007;35:1–13.PubMedCrossRef
14.
go back to reference Rismanchi N, Soderblom C, Stadler J, Zhu PP, Blackstone C. Atlastin GTPases are required for Golgi apparatus and er morphogenesis. Hum Mol Genet. 2008;17:1591–604.PubMedCrossRef Rismanchi N, Soderblom C, Stadler J, Zhu PP, Blackstone C. Atlastin GTPases are required for Golgi apparatus and er morphogenesis. Hum Mol Genet. 2008;17:1591–604.PubMedCrossRef
15.
go back to reference Muriel MP, Dauphin A, Namekawa M, Gervais A, Brice A, Ruberg M. Atlastin-1, the dynamin-like GTPase responsible for spastic paraplegia SPG3A, remodels lipid membranes and may form tubules and vesicles in the endoplasmic reticulum. J Neurochem. 2009;110:1607–16.PubMedCrossRef Muriel MP, Dauphin A, Namekawa M, Gervais A, Brice A, Ruberg M. Atlastin-1, the dynamin-like GTPase responsible for spastic paraplegia SPG3A, remodels lipid membranes and may form tubules and vesicles in the endoplasmic reticulum. J Neurochem. 2009;110:1607–16.PubMedCrossRef
16.
go back to reference Orso G, Pendin D, Liu S, Tosetto J, Moss TJ, Faust JE, et al. Homotypic fusion of er membranes requires the dynamin-like GTPase atlastin. Nature. 2009;460:978–83.PubMedCrossRef Orso G, Pendin D, Liu S, Tosetto J, Moss TJ, Faust JE, et al. Homotypic fusion of er membranes requires the dynamin-like GTPase atlastin. Nature. 2009;460:978–83.PubMedCrossRef
17.
go back to reference Evans K, Keller C, Pavur K, Glasgow K, Conn B, Lauring B. Interaction of two hereditary spastic paraplegia gene products, spastin and atlastin, suggests a common pathway for axonal maintenance. Proc Natl Acad Sci USA. 2006;103:10666–71.PubMedCrossRef Evans K, Keller C, Pavur K, Glasgow K, Conn B, Lauring B. Interaction of two hereditary spastic paraplegia gene products, spastin and atlastin, suggests a common pathway for axonal maintenance. Proc Natl Acad Sci USA. 2006;103:10666–71.PubMedCrossRef
18.
go back to reference Sanderson CM, Connell JW, Edwards TL, Bright NA, Duley S, Thompson A, et al. Spastin and atlastin, two proteins mutated in autosomal-dominant hereditary spastic paraplegia, are binding partners. Hum Mol Genet. 2006;15:307–18.PubMedCrossRef Sanderson CM, Connell JW, Edwards TL, Bright NA, Duley S, Thompson A, et al. Spastin and atlastin, two proteins mutated in autosomal-dominant hereditary spastic paraplegia, are binding partners. Hum Mol Genet. 2006;15:307–18.PubMedCrossRef
19.
go back to reference McMonagle P, Byrne P, Hutchinson M. Further evidence of dementia in SPG4-linked autosomal dominant hereditary spastic paraplegia. Neurology. 2004;62:407–10.PubMedCrossRef McMonagle P, Byrne P, Hutchinson M. Further evidence of dementia in SPG4-linked autosomal dominant hereditary spastic paraplegia. Neurology. 2004;62:407–10.PubMedCrossRef
20.
go back to reference Murphy S, Gorman G, Beetz C, Byrne P, Dytko M, McMonagle P, et al. Dementia in SPG4 hereditary spastic paraplegia: clinical, genetic, and neuropathologic evidence. Neurology. 2009;73:378–84.PubMedCrossRef Murphy S, Gorman G, Beetz C, Byrne P, Dytko M, McMonagle P, et al. Dementia in SPG4 hereditary spastic paraplegia: clinical, genetic, and neuropathologic evidence. Neurology. 2009;73:378–84.PubMedCrossRef
21.
go back to reference Scheuer KH, Nielsen JE, Krabbe K, Simonsen C, Koefoed P, Sorensen SA, et al. Reduced regional cerebral blood flow in SPG4-linked hereditary spastic paraplegia. J Neurol Sci. 2005;235:23–32.PubMedCrossRef Scheuer KH, Nielsen JE, Krabbe K, Simonsen C, Koefoed P, Sorensen SA, et al. Reduced regional cerebral blood flow in SPG4-linked hereditary spastic paraplegia. J Neurol Sci. 2005;235:23–32.PubMedCrossRef
22.
go back to reference Charvin D, Cifuentes-Diaz C, Fonknechten N, Joshi V, Hazan J, Melki J, et al. Mutations of SPG4 are responsible for a loss of function of spastin, an abundant neuronal protein localized in the nucleus. Hum Mol Genet. 2003;12:71–8.PubMedCrossRef Charvin D, Cifuentes-Diaz C, Fonknechten N, Joshi V, Hazan J, Melki J, et al. Mutations of SPG4 are responsible for a loss of function of spastin, an abundant neuronal protein localized in the nucleus. Hum Mol Genet. 2003;12:71–8.PubMedCrossRef
23.
go back to reference Wharton SB, McDermott CJ, Grierson AJ, Wood JD, Gelsthorpe C, Ince PG, et al. The cellular and molecular pathology of the motor system in hereditary spastic paraparesis due to mutation of the spastin gene. J Neuropathol Exp Neurol. 2003;62:1166–77.PubMed Wharton SB, McDermott CJ, Grierson AJ, Wood JD, Gelsthorpe C, Ince PG, et al. The cellular and molecular pathology of the motor system in hereditary spastic paraparesis due to mutation of the spastin gene. J Neuropathol Exp Neurol. 2003;62:1166–77.PubMed
24.
go back to reference Abrahams S, Goldstein LH, Kew JJ, Brooks DJ, Lloyd CM, Frith CD, et al. Frontal lobe dysfunction in amyotrophic lateral sclerosis. A pet study. Brain. 1996;119(Pt 6):2105–20.PubMedCrossRef Abrahams S, Goldstein LH, Kew JJ, Brooks DJ, Lloyd CM, Frith CD, et al. Frontal lobe dysfunction in amyotrophic lateral sclerosis. A pet study. Brain. 1996;119(Pt 6):2105–20.PubMedCrossRef
25.
go back to reference van der Graaff MM, de Jong JM, Baas F, de Visser M. Upper motor neuron and extra-motor neuron involvement in amyotrophic lateral sclerosis: a clinical and brain imaging review. Neuromuscul Disord. 2009;19:53–8.PubMedCrossRef van der Graaff MM, de Jong JM, Baas F, de Visser M. Upper motor neuron and extra-motor neuron involvement in amyotrophic lateral sclerosis: a clinical and brain imaging review. Neuromuscul Disord. 2009;19:53–8.PubMedCrossRef
26.
go back to reference Lomen-Hoerth C, Murphy J, Langmore S, Kramer JH, Olney RK, Miller B. Are amyotrophic lateral sclerosis patients cognitively normal? Neurology. 2003;60:1094–7.PubMedCrossRef Lomen-Hoerth C, Murphy J, Langmore S, Kramer JH, Olney RK, Miller B. Are amyotrophic lateral sclerosis patients cognitively normal? Neurology. 2003;60:1094–7.PubMedCrossRef
27.
go back to reference Geser F, Martinez-Lage M, Robinson J, Uryu K, Neumann M, Brandmeir NJ, et al. Clinical and pathological continuum of multisystem TDP-43 proteinopathies. Arch Neurol. 2009;66:180–9.PubMedCrossRef Geser F, Martinez-Lage M, Robinson J, Uryu K, Neumann M, Brandmeir NJ, et al. Clinical and pathological continuum of multisystem TDP-43 proteinopathies. Arch Neurol. 2009;66:180–9.PubMedCrossRef
Metadata
Title
SPG3A-linked hereditary spastic paraplegia associated with cerebral glucose hypometabolism
Authors
Tatsuhiro Terada
Satoshi Kono
Yasuomi Ouchi
Kenichi Yoshida
Yasushi Hamaya
Shigeru Kanaoka
Hiroaki Miyajima
Publication date
01-04-2013
Publisher
Springer Japan
Published in
Annals of Nuclear Medicine / Issue 3/2013
Print ISSN: 0914-7187
Electronic ISSN: 1864-6433
DOI
https://doi.org/10.1007/s12149-012-0673-5

Other articles of this Issue 3/2013

Annals of Nuclear Medicine 3/2013 Go to the issue